will fda ban compounded semaglutide 🚨 Moves to Permanently Shut Down GLP-1s The FDA is taking steps to eliminate large-scale compounding of GLP-1 medications like and tirzepatide, signaling a major shift in how these Will Compounded Semaglutide Be Discontinued?

Potential benefits are not guaranteed

But the popularity of GLP-1 medications spiked after the approval of Ozempic in 2017

[8] [9] It is worth noting that whilst these strategies support overall metabolic health, they are not substitutes for prescribed medication when clinically indicated

According to the NIH (National Institute of Health), just 5% reduction from baseline weight is associated with meaningful clinical improvement

Guyard et al., 2022

In this review, we focus on how GLP-1 receptor agonists, insulin and other incretin mimetics exert multiple neuroprotective effects and could provide an effective new therapeutic strategy for neurodegenerative diseases